Infection Risk-Adjusted Antibiotic Prophylaxis Strategies in Arthroplasty: Short Review of Evidence and Experiences of a Tertiary Center in Spain

References

• Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019;4(7):482–494. doi:10.1302/2058-5241.4.18009231423332
   PubMed Web of Science ®Google Scholar
• Lamagni T. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014;69(Suppl 1):i5–10. doi:10.1093/jac/dku24725135091
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Beswick AD, Peters TJ, et al. Health care needs and support for patients undergoing treatment for prosthetic joint infection following hip or knee arthroplasty: a systematic review. PLoS One. 2017;12(1):e0169068. doi:10.1371/journal.pone.016906828046049
   PubMed Web of Science ®Google Scholar
• Wang FD, Wang YP, Chen CF, Chen HP. The incidence rate, trend and microbiological aetiology of prosthetic joint infection after total knee arthroplasty: a 13 years’ experience from a tertiary medical center in Taiwan. J Microbiol Immunol Infect. 2018;51(6):717–722. doi:10.1016/j.jmii.2018.08.01130228089
   PubMedGoogle Scholar
• Lenguerrand E, Whitehouse MR, Beswick AD, Toms AD, Porter ML, Blom AW. Description of the rates, trends and surgical burden associated with revision for prosthetic joint infection following primary and revision knee replacements in England and Wales: an analysis of the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. BMJ Open. 2017;7(7):e014056. doi:10.1136/bmjopen-2016-014056
   PubMed Web of Science ®Google Scholar
• Pilz V, Hanstein T, Skripitz R. Projections of primary hip arthroplasty in Germany until 2040. Acta Orthop. 2018;89(3):308–313. doi:10.1080/17453674.2018.144646329504824
   PubMed Web of Science ®Google Scholar
• Robertsson O, Ranstam J, Sundberg M, W-Dahl A, Lidgren L. The Swedish knee arthroplasty register: a review. Bone Joint Res. 2014;3(7):217–222. doi:10.1302/2046-3758.37.200028924986492
   PubMed Web of Science ®Google Scholar
• Benito N, Franco M, Ribera A, et al. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect. 2016;22(8):732.e1–8. doi:10.1016/j.cmi.2016.05.004
   Web of Science ®Google Scholar
• Iorio R, Williams KM, Marcantonio AJ, Specht LM, Tilzey JF, Healy WL. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty. 2012;27(5):726–9.e1. doi:10.1016/j.arth.2011.09.01322054905
   PubMed Web of Science ®Google Scholar
• Dale H, Fenstad AM, Hallan G, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2012;83(5):449–458. doi:10.3109/17453674.2012.73391823083433
   PubMed Web of Science ®Google Scholar
• Badawy M, Espehaug B, Fenstad AM, et al. Patient and surgical factors affecting procedure duration and revision risk due to deep infection in primary total knee arthroplasty. BMC Musculoskelet Disord. 2017;18(1):544. doi:10.1186/s12891-017-1915-429268748
   PubMed Web of Science ®Google Scholar
• Lenguerrand E, Whitehouse MR, Beswick AD, et al. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales. Lancet Infect Dis. 2019;19(6):589–600. doi:10.1016/S1473-3099(18)30755-231005559
   PubMed Web of Science ®Google Scholar
• Jämsen E, Huhtala H, Puolakka T, Moilanen T. Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am. 2009;91(1):38–47. doi:10.2106/JBJS.G.01686
   PubMed Web of Science ®Google Scholar
• Machado S, Marta M, Rodrigues P, et al. Risk factors for infection after total knee arthroplasty and prevention strategies. Orthop Proc. 2018;97:122.
   Google Scholar
• Alamanda VK, Springer BD. The prevention of infection: 12 modifiable risk factors. Bone Joint J. 2019;101-B:3–9. doi:10.1302/0301-620X.101B1
   PubMed Web of Science ®Google Scholar
• Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008;466(7):1710–1715. doi:10.1007/s11999-008-0209-418421542
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866. doi:10.1371/journal.pone.015086626938768
   PubMed Web of Science ®Google Scholar
• Osmon DR. Microbiology and antimicrobial challenges of prosthetic joint infection. J Am Acad Orthop Surg. 2017;25(Suppl 1):S17–S19. doi:10.5435/JAAOS-D-16-0063927922947
   PubMed Web of Science ®Google Scholar
• Peel TN, Cheng AC, Buising KL, Choong PF. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother. 2012;56(5):2386–2391. doi:10.1128/AAC.06246-1122314530
   PubMed Web of Science ®Google Scholar
• AAOS ortho guidelines 2015 Available from: http://www.orthoguidelines.org/guideline-detail?id=1514. Accessed 79, 2020.
   Google Scholar
• Lazarinis S, Lidgren L, Stefánsdóttir A, Dahl AW. Consensus document on prosthetic joint infections. Acta Orthop. 2013;84(6):507–508. doi:10.3109/17453674.2013.86739924286568
   PubMed Web of Science ®Google Scholar
• Peersman G, Laskin R, Davis J, Peterson M, Richart T. Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J. 2006;2(1):70–72. doi:10.1007/s11420-005-0130-218751850
   PubMedGoogle Scholar
• Cheng H, Chen B, Soleas I, et al. Prolonged operative duration increases risk of surgical site infections: a systematic review. Surg Infect. 2017;18(6):722–735. doi:10.1089/sur.2017.089
   PubMed Web of Science ®Google Scholar
• Garbarino L, Gold P, Sodhi N, et al. The effect of operative time on in-hospital length of stay in revision total knee arthroplasty. Ann Transl Med. 2019;7(4):66. doi:10.21037/atm.2019.01.5430963061
   PubMed Web of Science ®Google Scholar
• Ravi B, Jenkinson R, O’Heireamhoin S, et al. Surgical duration is associated with an increased risk of periprosthetic infection following total knee arthroplasty: a population-based retrospective cohort study. EClinicalMedicine. 2019;16:74–80. doi:10.1016/j.eclinm.2019.09.01531832622
   PubMedGoogle Scholar
• Chalmers BP, Weston JT, Osmon DR, Hanssen AD, Berry DJ, Abdel MP. Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: a matched control study. Bone Joint J. 2019;101-B(7_Supple_C):91–97. doi:10.1302/0301-620X.101B7.BJJ-2018-1189.R1
   Web of Science ®Google Scholar
• Bedair H, Goyal N, Dietz MJ, et al. A history of treated periprosthetic joint infection increases the risk of subsequent different site infection. Clin Orthop Relat Res. 2015;473(7):2300–2304. doi:10.1007/s11999-015-4174-425670654
   PubMed Web of Science ®Google Scholar
• Prokuski L, Clyburn TA, Evans RP, Moucha CS. Prophylactic antibiotics in orthopaedic surgery. Instr Course Lect. 2011;60:545–555.21553797
   PubMedGoogle Scholar
• Siddiqi A, Forte SA, Docter S, Bryant D, Sheth NP, Chen AF. Perioperative antibiotic prophylaxis in total joint arthroplasty: a systematic review and meta-analysis. J Bone Joint Surg Am. 2019;101(9):828–842. doi:10.2106/JBJS.18.0099031045673
   PubMed Web of Science ®Google Scholar
• Wyles CC, Hevesi M, Osmon DR, et al. 2019 John Charnley Award: increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis. Bone Joint J. 2019;101-B(6_Supple_B):9–15. doi:10.1302/0301-620X.101B6.BJJ-2018-1407.R131146571
   PubMed Web of Science ®Google Scholar
• Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J. Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin. Clin Orthop Relat Res. 2017;475(7):1767–1774. doi:10.1007/s11999-017-5302-028401341
   PubMed Web of Science ®Google Scholar
• Tan TL, Shohat N, Rondon AJ, et al. Perioperative antibiotic prophylaxis in total joint arthroplasty: a single dose is as effective as multiple doses. J Bone Joint Surg Am. 2019;101(5):429–437. doi:10.2106/JBJS.18.0033630845037
   PubMed Web of Science ®Google Scholar
• Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14:73–156. doi:10.1089/sur.2013.9999
   PubMed Web of Science ®Google Scholar
• Löwik C, Zijlstra WP, Knobben BAS, et al. Obese patients have higher rates of polymicrobial and gram-negative early periprosthetic joint infections of the hip than non-obese patients. PLoS One. 2019;14(4):e0215035. doi:10.1371/journal.pone.021503530958847
   PubMed Web of Science ®Google Scholar
• Nodzo SR, Boyle KK, Frisch NB. Nationwide organism susceptibility patterns to common preoperative prophylactic antibiotics: what are we covering? J Arthroplasty. 2019;34(7S):302–306. doi:10.1016/j.arth.2019.01.017
   Web of Science ®Google Scholar
• Available from: https://www.ecdc.europa.eu/en/publications-data/systematic-review-and-evidence-based-guidance-perioperative-antibiotic-prophylaxis. Accessed 79, 2020.
   Google Scholar
• Sewick A, Makani A, Wu C, O’Donnell J, Baldwin KD, Lee GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res. 2012;470(10):2702–2707. doi:10.1007/s11999-012-2255-122290130
   PubMed Web of Science ®Google Scholar
• Liu C, Kakis A, Nichols A, Ries MD, Vail TP, Bozic KJ. Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA. Clin Orthop Relat Res. 2014;472(1):227–231. doi:10.1007/s11999-013-3029-023645338
   PubMed Web of Science ®Google Scholar
• Tornero E, García-Ramiro S, Martínez-Pastor JC, et al. Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty. Antimicrob Agents Chemother. 2015;59(2):831–837. doi:10.1128/AAC.03949-1425403662
   PubMed Web of Science ®Google Scholar
• Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee GC. Addition of vancomycin to cefazolin prophylaxis Is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res. 2015;473(7):2197–2203. doi:10.1007/s11999-014-4062-325421958
   PubMed Web of Science ®Google Scholar
• Claret G, Tornero E, Martínez-Pastor JC, et al. A prolonged post-operative antibiotic regimen reduced the rate of prosthetic joint infection after aseptic revision knee arthroplasty. Surg Infect. 2015;16(6):775–780. doi:10.1089/sur.2015.044
   Web of Science ®Google Scholar
• Inabathula A, Dilley JE, Ziemba-Davis M, et al. Extended oral antibiotic prophylaxis in high-risk patients substantially reduces primary total hip and knee arthroplasty 90-day infection rate. J Bone Joint Surg Am. 2018;100(24):2103–2109. doi:10.2106/JBJS.17.0148530562290
   PubMed Web of Science ®Google Scholar
• DeFrancesco CJ, Fu MC, Kahlenberg CA, Miller AO, Bostrom MP. Extended antibiotic prophylaxis may be linked to lower peri-prosthetic joint infection rates in high-risk patients: an evidence-based review. HSS J. 2019;15(3):297–301. doi:10.1007/s11420-019-09698-831624486
   PubMedGoogle Scholar
• Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE. The type of cement and failure of total hip replacements. J Bone Joint Surg Br. 2002;84(6):832–838. doi:10.1302/0301-620X.84B6.084083212211673
   PubMedGoogle Scholar
• Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop. 2008;79:335–341. doi:10.1080/1745367071001522918622836
   PubMed Web of Science ®Google Scholar
• King JD, Hamilton DH, Jacobs CA, Duncan ST. The hidden cost of commercial antibiotic-loaded bone cement: a systematic review of clinical results and cost implications following total knee arthroplasty. J Arthroplasty. 2018;33:3789. doi:10.1016/j.arth.2018.08.00930217400
   PubMed Web of Science ®Google Scholar
• Sanz-Ruiz P, Matas-Diez JA, Sanchez-Somolinos M, Villanueva-Martinez M, Vaquero-Martin J. Is the commercial antibiotic-loaded bone cement useful in prophylaxis and cost saving after knee and hip joint arthroplasty? The transatlantic paradox. J Arthroplasty. 2017;32(4):1095–1099. doi:10.1016/j.arth.2016.11.01227919578
   PubMed Web of Science ®Google Scholar
• Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res. 2008;466(6):1492–1498. doi:10.1007/s11999-008-0203-x18338216
   PubMed Web of Science ®Google Scholar
• Sprowson AP, Jensen C, Chambers S, et al. The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip: the fractured hip infection trial. Bone Joint J. 2016;98-B(11):1534–1541. doi:10.1302/0301-620X.98B11.3469327803231
   PubMed Web of Science ®Google Scholar
• Savage P, McCormick M, Al-Dadah O. Arthroplasty infection rates in fractured neck of femur: single vs dual antibiotic cement. Ann R Coll Surg Engl. 2019;101:514–518. doi:10.1308/rcsann.2019.005431155899
   PubMed Web of Science ®Google Scholar
• Sanz-Ruiz P, Matas-Diez JA, Sanchez-Somolinos M, Vaquero-Martín J. Is dual antibiotic loaded bone cement more effective and cost-efficient than a single antibiotic loaded bone cement to reduce prosthetic joint infections in patients at higher infection risks? - A retrospective study in aseptic revision knee arthroplasty. J Arthroplasty. 2020. doi:10.1016/j.arth.2020.06.045
   Web of Science ®Google Scholar